Loading data
TRDANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25.42 m USD | 210.78 m USD | 129.01 m USD | — | — |
| Research and development expense | 142.27 m USD | 125.31 m USD | 99.88 m USD | 66.61 m USD | 35.93 m USD |
| Operating profit | -157.9 m USD | 47.01 m USD | -3.16 m USD | -97.25 m USD | -51.13 m USD |
| Income tax expense | 924 k USD | 900 k USD | 18.74 m USD | 0 USD | — |
| Net income (reported basis) | -143.75 m USD | 65.63 m USD | -6.69 m USD | -94.6 m USD | -51.16 m USD |
| Basic earnings per share | -3.47 USD/share | 1.76 USD/share | -0.2 USD/share | -3.02 USD/share | -8.16 USD/share |
| Diluted earnings per share | -3.47 USD/share | 1.68 USD/share | -0.2 USD/share | -3.02 USD/share | -8.16 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.